Medical Sales Representative at New Heights Pharmaceuticals Limited - 3 Openings | Careersngr : Careersngr

Advertisements

Medical Sales Representative at New Heights Pharmaceuticals Limited – 3 Openings

Filed in by on January 31, 2024
Full Time Jobs in Nigeria
JOBS IN KANO STATE - JOB VACANCIES IN KANO, JOBS IN LAGOS STATE - JOB VACANCIES IN LAGOS STATE NIGERIA, JOBS IN RIVERS STATE - JOB VACANCIES IN RIVERS NIGERIA
Posted 3 months ago

New Heights Pharmaceuticals Limited is inviting credible applicants who are willing to partake in its ongoing recruitment to fill the position below:

Advertisements

Job Title: Medical Sales Representative

Locations: Port Harcourt – Rivers, Lagos and Kano 
Employment Type: Full-time

About New Heights Pharmaceuticals Limited: New Heights Pharmaceuticals Limited is a wholly indigenous healthcare company registered in 2004 under the Companies and Allied Matters Act but started business fully February, 2005. The company started as a wholesale business with just two (2) staff.

Advertisements

 Job Requirements

  • Bachelor’s Degree in Pharmacy and Biological Sciences, Natural Sciences, or related field.
  • 2 – 5 years work experience.
  • Proven medical/pharma sales experience added advantage.
  • Experience in hospital detailing and sales generation is an added advantage.
  • Proficient in Microsoft Word, Excel, Outlook, and PowerPoint.
  • Valid driver’s license.
  • Strong negotiation skills.
  • Excellent organizational skills.
  • Effective communication skills.
  • Exceptional customer service skills.
  • Persuasive and resilient.
  • Highly motivated and target driven with a proven track record in sales.
  • Ability to travel frequently.

 How to Submit Your Application

Interested and qualified candidates should send their Applications and CV to: [email protected] using the job title as the subject of the mail.

 Application Closing Date
10th February, 2024.

Job Features

Job CategoryPublic Relation / Liaison / Arbitrator / Representative Jobs in Nigeria

Apply Online

Comments are closed.